Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unlocking methodological insights on oncology efficacy endpoints: from statistical to clinical and vice versa. Letter to the editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3' by M. P. Goetz et al.
De Sanctis R, Bruzzi P, Zambelli A. De Sanctis R, et al. Among authors: zambelli a. Ann Oncol. 2024 Sep 3:S0923-7534(24)03925-5. doi: 10.1016/j.annonc.2024.08.2345. Online ahead of print. Ann Oncol. 2024. PMID: 39236982 No abstract available.
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review.
Miglietta F, Fabi A, Generali D, Dieci MV, Arpino G, Bianchini G, Cinieri S, Conte PF, Curigliano G, De Laurentis M, Del Mastro L, De Placido S, Gennari A, Puglisi F, Zambelli A, Perrone F, Guarneri V. Miglietta F, et al. Among authors: zambelli a. Cancer Treat Rev. 2023 Mar;114:102511. doi: 10.1016/j.ctrv.2023.102511. Epub 2023 Jan 6. Cancer Treat Rev. 2023. PMID: 36638600 Free article. Review.
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treatm. Rev. 114 (2023) 102511].
Miglietta F, Fabi A, Generali D, Dieci MV, Arpino G, Bianchini G, Cinieri S, Conte PF, Curigliano G, De Laurentiis M, Del Mastro L, De Placido S, Gennari A, Puglisi F, Zambelli A, Perrone F, Guarneri V. Miglietta F, et al. Among authors: zambelli a. Cancer Treat Rev. 2023 Jun;117:102570. doi: 10.1016/j.ctrv.2023.102570. Epub 2023 May 5. Cancer Treat Rev. 2023. PMID: 37150120 Free article. No abstract available.
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treat. Rev. 114 (2023) 102511].
Miglietta F, Fabi A, Generali D, Dieci MV, Arpino G, Bianchini G, Cinieri S, Conte PF, Curigliano G, De Laurentiis M, Del Mastro L, De Placido S, Gennari A, Puglisi F, Zambelli A, Perrone F, Guarneri V. Miglietta F, et al. Among authors: zambelli a. Cancer Treat Rev. 2023 Sep;119:102594. doi: 10.1016/j.ctrv.2023.102594. Epub 2023 Jul 1. Cancer Treat Rev. 2023. PMID: 37400291 Free article. No abstract available.
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies.
Birtolo MF, Pedersini R, Palermo A, Vena W, Morenghi E, Cristofolini G, Presciuttini B, Tabacco G, Naciu AM, Pigni S, Laganà M, Mazzoleni F, Cosentini D, Ciafardini A, Pagani M, Farina D, Balzarini L, Zambelli A, Torrisi R, Cianferotti L, Napoli N, Bossi AC, Lania AG, Berruti A, Mazziotti G. Birtolo MF, et al. Among authors: zambelli a. Eur J Endocrinol. 2024 Aug 5;191(2):117-125. doi: 10.1093/ejendo/lvae086. Eur J Endocrinol. 2024. PMID: 39056237
Ovarian Cancer in a Northern Italian Province and the Multidisciplinary Team.
Mangone L, Marinelli F, Bisceglia I, Braghiroli MB, Mastrofilippo V, Cerullo L, Pellegri C, Zambelli A, Aguzzoli L, Mandato VD. Mangone L, et al. Among authors: zambelli a. Cancers (Basel). 2022 Dec 31;15(1):299. doi: 10.3390/cancers15010299. Cancers (Basel). 2022. PMID: 36612295 Free PMC article.
297 results